2.05
+0.02(+0.99%)
Currency In USD
| Previous Close | 2.03 |
| Open | 2.06 |
| Day High | 2.07 |
| Day Low | 2.04 |
| 52-Week High | 9.19 |
| 52-Week Low | 1.83 |
| Volume | 25,349 |
| Average Volume | 215,676 |
| Market Cap | 18.14M |
| PE | -0.95 |
| EPS | -2.16 |
| Moving Average 50 Days | 2.1 |
| Moving Average 200 Days | 2.71 |
| Change | 0.02 |
If you invested $1000 in Daré Bioscience, Inc. (DARE) 10 years ago, it would be worth $4.7 as of October 20, 2025 at a share price of $2.03. Whereas If you bought $1000 worth of Daré Bioscience, Inc. (DARE) shares 5 years ago, it would be worth $162.66 as of October 20, 2025 at a share price of $2.03.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Daré Bioscience Receives $4 Million Non-Dilutive Grant Installment; Total of $41.8M Received to Date of up to $49M Commitment Supporting Smart Drug Delivery Device for Contraception; Platform has Broader Application Potential in Obesity and Metabolic Disorders
GlobeNewswire Inc.
Oct 06, 2025 12:00 PM GMT
Exploring Strategic Partnerships to Expand Platform Beyond Reproductive HealthSAN DIEGO, Oct. 06, 2025 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a biopharmaceutical company with a sole focus of closing the gap in women's health betw
Daré Bioscience to Receive up to $499,000 to Support Preeclampsia Research
GlobeNewswire Inc.
Sep 24, 2025 12:00 PM GMT
Engagement Will Expand Daré’s Engagement in Advancing Women’s Health Innovation and Provide Insights into One of the Most Significant Unmet Needs in Maternal CareSAN DIEGO, Sept. 24, 2025 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a
Daré Bioscience to Host Second Quarter 2025 Financial Results and Company Update Conference Call and Webcast on August 14, 2025
GlobeNewswire Inc.
Aug 07, 2025 12:00 PM GMT
SAN DIEGO, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a biopharmaceutical company with a sole focus of closing the gap in women’s health between promising science and real solutions, will host a conference call and li